Piceatannol, a resveratrol derivative, promotes glucose uptake through glucose transporter 4 translocation to plasma membrane in L6 myocytes and suppresses blood glucose levels in type 2 diabetic model db/db mice

Biochemical and Biophysical Research Communications

Volumn 422, Issue 3, 2012, Pages 469-475

  Minakawa, Miki ^a   Miura, Yutaka ^a   Yagasaki, Kazumi ^a,b  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

AMPK; Diabetic db db mice; Glucose transporter 4; L6 myocyte; Piceatannol

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; PICEATANNOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL MEMBRANE; DRUG MECHANISM; ENZYME PHOSPHORYLATION; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HYPERGLYCEMIA; IMMUNOCYTOCHEMISTRY; IMPAIRED GLUCOSE TOLERANCE; MALE; MOUSE; MUSCLE CELL; MYOBLAST; MYOTUBE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

ANIMALS; BLOOD GLUCOSE; CELL LINE; CELL MEMBRANE; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; MICE; MOLECULAR IMAGING; MUSCLE CELLS; PROTEIN KINASES; RATS; STILBENES;

MUS;

EID: 84861933793     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.05.017     Document Type: Article

References (20)

1. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
2. Barrett M.L., Udani J.K. A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): a review of clinical studies on weight loss and glycemic control. Nutr. J. 2011, 10:24. 10.1186/1475-2891-10-24.
3. Moller D.E. Metabolic disease drug discovery-" hitting the target" is easier said than done. Cell Metab. 2012, 15:19-24.
4. Saltiel A.R., Kahan C.R. Insulin signaling and the regulation of glucose and lipid metabolism. Nature 2001, 414:799-806.
5. Towler M.C., Hardie D.G. AMP-activated protein kinase in metabolic control and insulin signaling. Cirs. Res. 2007, 100:328-341.
6. Hardie D.G. AMP-activated protein kinase: a key system mediating metabolic responses to exercise. Med. Sci. Sports Exerc. 2004, 36:28-34.
7. Zou M.H., Kirkpatrick S.S., Davis B.J., Nelson J.S., Wiles W.G., Schlattner U., Neumann D., Brownlee M., Freeman M.B., Goldman M.H. Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species. J. Biol. Chem. 2004, 279:43940-43951.
8. Huang S., Czech M.P. The GLUT4 glucose transporter. Cell Metab. 2007, 5:237-252.
9. Larrosa M., Tomás-Barberán F.A., Espín J.C. The grapes and wine polyphenol piceatannol is a potent inducer of apoptosis in human SK-Mel-28 melanoma cells. Eur. J. Nutr. 2004, 43:275-284.
10. Smoliga J.M., Baur J.A., Hausenblas H.A. Resveratrol and health - A comprehensive review of human clinical trials. Mol. Nutr. Food Res. 2011, 55:1129-1141.
11. Kwon J.Y., Seo S.G., Heo Y.S., Yue S., Cheng J.X., Lee K.W., Kim K.H. Piceatannol, a natural polyphenolic stilbene, inhibits adipogenesis via modulation of mitotic clonal expansion and insulin receptor-dependent insulin signaling in the early phase of differentiation. J. Biol. Chem. 2012, 287:11566-11578.
12. Kozuki Y., Miura Y., Yagasaki K. Resveratrol suppresses hepatoma cell invasion independently of its anti-proliferative activity. Cancer Lett. 2001, 167:151-156.
13. Kita Y., Miura Y., Yagasaki K. Antiproliferative and anti-invasive effect of piceatannol, a polyphenol present in grapes and wine, against hepatoma AH109A cells. J. Biomed. Biotechnol. 2012, 2012:672416. 10.1155/2012/672416.
14. Yagasaki K., Morisaki N., Kitahara Y., Miura A., Funabiki R. Involvement of protein kinase C activation in l-leucine-induced stimulation of protein synthesis in L6 myotubes. Cytotechnology 2003, 43:97-103.
15. Kawano A., Nakamura H., Hata S., Minakawa M., Miura Y., Yagasaki K. Hypoglycemic effect of aspalathin, a rooibos tea component from Aspalathus linearis, in type 2 diabetic model db/db mice. Phytomedicine 2009, 16:437-443.
16. Nishitani S., Matsumura T., Fujitani S., Sonaka I., Miura Y., Yagasaki K. Leucine promotes glucose uptake in skeletal muscles of rats. Biochem. Biophys. Res. Commun. 2002, 299:693-696.
17. Nishiumi S., Ashida H. Rapid preparation of a plasma membrane fraction from adipocytes and muscle cells: application to detection of translocated glucose transporter 4 on the plasma membrane. Biosci. Biotechnol. Biochem. 2007, 71:2342-2346.
18. Minakawa M., Kawano A., Miura Y., Yagasaki K. Hypoglycemic effect of resveratrol in type 2 diabetic model db/db mice and its actions in cultured L6 myotubes and RIN-5F pancreatic cells. J. Clin. Biochem. Nutr. 2011, 48:237-244.
19. Fecchi K., Volonte D., Hezel M.P., Schmeck K., Galbiati F. Spatial and temporal regulation of GLUT4 translocation by flotillin-1 and caveolin-3 in skeletal muscle cells. FASEB J. 2006, 20:705-707.
20. Ha B.G., Nagaoka M., Yonezawa T., Tanabe R., Woo J.T., Kato H., Chung U.I., Yagasaki K. Regulatory mechanism for the stimulatory action of genistein on glucose uptake in vitro and in vivo. J. Nutr. Biochem. 2012, 23:501-509.